Fundraising Fox

Brett Chevalier

Investor

Venture Partner at Anterra Capital

Cambridge, Massachusetts

Writes $1M – $20M checks · typically $5M

Find your path to Brett

2,349 people in our graph share verified history with Brett — schools, employers, funds. One of them is your warm intro.

Kyle DohertyunlockedBrett: together at Massachusetts Institute of Technology (2002–2004)
×9Brett: together at Massachusetts Institute of Technology
Brett: together at University of Washington
Brett: together at Flagship Ventures

About

Brett Chevalier serves as Chief Scientific Officer at Anterra Capital, where he focuses on company creation in the biosciences. His work spans human therapeutics and discovery platforms, with expanding interests in biotech applications for animal health, agriculture, and environmental solutions.

Experience

  1. Anterra CapitalChief Scientific Officercurrent2018 — presentBoston, Massachusetts
  2. Orogen TherapeuticsScientific Co-Founder, Interim VP Ops and CSO, Board Observercurrent2023 — presentGreater Boston
  3. BiomEditBoard Observercurrent2022 — presentIndiana, United States
  4. Animol Discovery, Inc.Scientific Co-Founder, SAB, Board Observercurrent2020 — presentGreater Boston
  5. CAMP4 TherapeuticsHead Of Operations2015 — 2018Cambridge, MA
  6. CorviumAdvisor2010 — 2016Boston, MA
  7. CorviumFounder and Chief Scientific Officer2010 — 2012Greater Boston Area
  8. Flagship VenturesNew Venture Associate2008 — 2009Cambridge, MA
  9. Whitehead InstituteResearch Scientist2006 — 2008Cambridge, MA
  10. Agilent TechnologiesSenior Scientist (Systems Biology)2005 — 2006Cambridge, MA

Skills & more

Team LeadershipStart-ups2Entrepreneurship2Technical LeadershipStrategic LeadershipBusiness StrategyVenture Capital3FundraisingPatentsPatent ApplicationsTechnology Transfer3Patent Portfolio Analysis
+9 moreProtein EngineeringProtein CrystallizationProtein ExpressionMicrobiologyEmbryonic Stem CellsCancer ResearchCancer Stem CellsProteomicsGenomics

From Brett's professional profile.

Colleagues at Anterra Capital

Network5

Investors connected to Brett in public investor directories — a warm-intro map.

Frequently asked questions

Who is Brett Chevalier?
Brett Chevalier serves as Chief Scientific Officer at Anterra Capital, where he focuses on company creation in the biosciences. His work spans human therapeutics and discovery platforms, with expanding interests in biotech applications for animal health, agriculture, and environmental solutions.
Where does Brett Chevalier work?
Brett Chevalier is Venture Partner at Anterra Capital.
What check size does Brett Chevalier write?
Brett Chevalier typically writes checks of $1M – $20M.
Where did Brett Chevalier go to school?
Brett Chevalier studied at Massachusetts Institute of Technology (Merck LSRF Fellow, Stem and iPS cells); University of Washington (PhD, Protein Design and Engineering); Carleton College (BA, Biology).

Founder mafias

Same school

Shared employers